Acurx Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Acurx Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ACXP | Acurx Pharmaceuticals | -$0.17 | -$2.87 | — | — | $0.00 | — | — | — | 11/12/2025 | |
ACXP | Acurx Pharmaceuticals | -$5.21 | -$0.14 | -$1.89 | 8.25% | $0.00 | — | $0.00 | — | 08/12/2025 | |
ACXP | Acurx Pharmaceuticals | -$0.28 | -$0.15 | -$0.11 | 62.07% | $0.00 | — | $0.00 | — | 05/13/2025 | |
ACXP | Acurx Pharmaceuticals | -$0.38 | -$0.38 | -$0.17 | 5.56% | $0.00 | — | $0.00 | — | 03/18/2025 | |
ACXP | Acurx Pharmaceuticals | -$0.24 | -$0.20 | -$0.17 | 15.00% | $0.00 | — | $0.00 | — | 11/12/2024 | |
ACXP | Acurx Pharmaceuticals | -$0.28 | -$0.21 | -$0.26 | -18.18% | $0.00 | — | $0.00 | — | 08/09/2024 | |
ACXP | Acurx Pharmaceuticals | -$0.25 | -$0.24 | -$0.28 | -16.67% | $0.00 | — | $0.00 | — | 05/14/2024 | |
ACXP | Acurx Pharmaceuticals | -$0.28 | -$0.26 | -$0.37 | -42.31% | $0.00 | — | $0.00 | — | 03/18/2024 | |
ACXP | Acurx Pharmaceuticals | -$0.32 | -$0.27 | -$0.24 | 11.11% | $0.00 | — | $0.00 | — | 11/14/2023 | |
ACXP | Acurx Pharmaceuticals | -$0.26 | -$0.29 | -$0.28 | 3.45% | $0.00 | — | $0.00 | — | 08/11/2023 | |
ACXP | Acurx Pharmaceuticals | -$0.26 | -$0.29 | -$0.25 | 13.79% | $0.00 | — | $0.00 | — | 05/12/2023 | |
ACXP | Acurx Pharmaceuticals | -$0.22 | -$0.35 | -$0.28 | 20.00% | $0.00 | — | $0.00 | — | 03/16/2023 | |
ACXP | Acurx Pharmaceuticals | -$0.46 | -$0.35 | -$0.32 | 8.57% | $0.00 | — | $0.00 | — | 11/14/2022 | |
ACXP | Acurx Pharmaceuticals | -$0.57 | -$0.35 | -$0.26 | 25.71% | $0.00 | — | $0.00 | — | 08/15/2022 | |
ACXP | Acurx Pharmaceuticals | -$0.21 | -$0.33 | -$0.26 | 21.21% | $0.00 | — | $0.00 | — | 05/11/2022 | |
ACXP | Acurx Pharmaceuticals | — | -$0.40 | -$0.22 | 45.00% | $0.00 | — | $0.00 | — | 03/17/2022 | |
ACXP | Acurx Pharmaceuticals | -$0.21 | — | -$0.46 | — | $0.00 | — | $0.00 | — | 11/15/2021 | |
ACXP | Acurx Pharmaceuticals | -$0.15 | — | -$0.58 | — | $0.00 | — | $0.00 | — | 08/16/2021 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-08-12 | $-1.89 | $-0.14 | 8.25 % |
Q1 | 2025-05-13 | $-0.11 | $-0.15 | 62.1 % |
Q4 | 2025-03-18 | $-0.17 | $-0.38 | 5.56 % |
Q3 | 2024-11-12 | $-0.17 | $-0.20 | 15.0 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Está previsto que Acurx Pharmaceuticals (ACXP) presente resultados el noviembre 12, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
El BPA real fue de $-1.89, que no alcanzó la estimación de $-0.14.
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.